WASHINGTON — Republicans redrew their line in the sand on drug-pricing issues Thursday, with two GOP lawmakers warning forcefully that stripping monopolies from manufacturers would “radically undermine innovation.”
Rep. Devin Nunes (Calif.), the top Republican on the House Ways and Means health subcommittee, and Rep. Kevin Brady (Texas) cast Democratic proposals as big-government industry takeovers in a letter addressed to the subcommittee’s top Democrat — even as other Republicans have hinted at willingness to crack down on monopolies for high-priced drugs.
“We reject any attempt to empower the Federal government to confiscate the intellectual property of a manufacturer that rejects the ‘best offer’ of Washington bureaucrats,” Nunes and Brady wrote.
About the Author Reprints
